Table 2.
Metabolic syndrome components and prevalence of metabolic syndrome and its risk factors by categories of dietary total antioxidant capacity: Tehran Lipid and Glucose Study¹
|
( n = 1938) |
|||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | P2 | |
| Total antioxidant capacity |
|
|
|
|
|
|
Range |
< 842 |
842-958 |
959-1080 |
> 1080 |
|
|
Median |
764 |
906 |
1014 |
1161 |
|
| Waist circumference (cm) |
90 ± 0.5 |
89.0 ± 0.5 |
89 ± 0.5 |
89 ± 0.5 |
0.44 |
| Fasting blood glucose (mg/dl) |
93 ± 1.1 |
91 ± 1.1 |
91 ± 1.1 |
90 ± 1.1 |
0.46 |
| Serum triglycerides (mg/dl) |
148 ± 3.7 |
142 ± 3.7 |
143 ± 3.7 |
137 ± 3.7 |
0.24 |
| HDL-c (mg/dl) |
42.2 ± 0.4 |
41.8 ± 0.4 |
42.2 ± 0.4 |
42.5 ± 0.4 |
0.71 |
| SBP (mmHg) |
112 ± 0.6 |
112 ± 0.6 |
111 ± 0.6 |
111 ± 0.6 |
0.75 |
| DBP (mmHg) |
74 ± 0.4 |
74 ± 0.4 |
73 ± 0.4 |
73 ± 0.4 |
0.12 |
| Abdominal obesity (%) |
44.2 |
43.7 |
46.5 |
38.8 |
0.10 |
| Hypertriglyceridemia (%) |
34.5 |
31.8 |
30.7 |
31.1 |
0.57 |
| Low HDL-c (%) |
49.2 |
50.9 |
51.2 |
47.6 |
0.65 |
| Hyperglycemia (%) |
22.7 |
25.2 |
24.1 |
28.0 |
0.28 |
| Hypertension (%) |
12.6 |
17.4 |
14.5 |
15.5 |
0.20 |
| Metabolic syndrome (%) | 24.6 | 27.5 | 27.4 | 25.9 | 0.69 |
1 Data are age-adjusted mean ± SEM.
2P for trend across quartiles of dietary phytochemical index was calculated using Chi square test or linear regression models with adjustment for sex and age.